How an AI solution can design new tuberculosis drug regimens
![](https://familymednews.com/wp-content/uploads/sites/15/2019/11/cfarmafoto3-tuberculosis-900x280.jpg)
With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs—including unlikely candidates—can be combined in new ways to create more effective treatments. “This could replace our traditional trial-and-error system for drug development that is comparatively slow and expensive,” said Sriram Chandrasekaran, U-M assistant professor of biomedical engineering, […]
Continue reading »